| Product Code: ETC13375862 | Publication Date: Apr 2025 | Updated Date: Aug 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
| Market Size (2025) | USD 0.58 Billion |
| Forecast Size (2032) | USD 0.87 Billion |
| CAGR | 10.00% |
| Base Year | 2025 |
| Forecast Period | 2026-2032 |
| Largest Region | North America |
| Fastest Growing Region | Asia |
| Largest Segment | Covered Stents |
| Fastest Growing Segment | Bare Metal Stents |
| Leading Companies | Boston Scientific, Terumo Corporation, Cook Medical, Medtronic, Weigao Group |

The Global Transjugular Intrahepatic Portosystemic Shunt Market was estimated at USD 0.58 Billion in 2025 and is projected to reach USD 0.87 Billion by 2032, growing at a CAGR of 10.00% from 2026 to 2032.
Currently, the Global Transjugular Intrahepatic Portosystemic Shunt (TIPS) market is witnessing substantive shifts due to the rising incidence of liver diseases, particularly portal hypertension and liver cirrhosis. These health challenges necessitate intervention strategies like TIPS, which creates an artificial connection between the portal and systemic veins, effectively alleviating symptoms.
The increasing emphasis on minimally invasive procedures is also reshaping the market dynamics. Patients and healthcare providers favor these strategies as they often result in shorter recovery times and fewer complications compared to surgical options, signifying a crucial evolution in how liver-related ailments are treated.
This graph illustrates the annual growth rates of the Global Transjugular Intrahepatic Portosystemic Shunt Market from 2022 to 2032, highlighting a steady upward trajectory and projected expansion over the forecast period.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate (%) | Major Drivers |
| 2022 | 7.06 | Hospitals increasingly prioritize sustainable practices, enhancing transjugular intrahepatic portosystemic shunt procedures. |
| 2023 | 5.39 | Emerging biosensor technology enhances the effectiveness of transjugular intrahepatic portosystemic shunts. |
| 2024 | 3.93 | In the European Union, updated reimbursement policies boost transjugular intrahepatic portosystemic shunt access. |
| 2025 | 7.32 | Transjugular intrahepatic portosystemic shunt adoption expands significantly across Asia-Pacific healthcare facilities. |
| 2026 | 6.62 | Chronic disease management programs reduce the input costs associated with transjugular intrahepatic portosystemic shunts. |
| 2027 | 5.38 | Increasing digital therapeutics capabilities enhance patient outcomes related to transjugular intrahepatic portosystemic shunts. |
| 2028 | 6.18 | While competitive dynamics evolve, transjugular intrahepatic portosystemic shunt technology remains essential for patient care. |
| 2029 | 8.01 | Supply chain optimization for medical-grade materials enhances transjugular intrahepatic portosystemic shunt production efficiency. |
| 2030 | 4.74 | Healthcare infrastructure investments improve transjugular intrahepatic portosystemic shunt delivery across various channels. |
| 2031 | 3.42 | A shift toward home-based care changes the demand for transjugular intrahepatic portosystemic shunt solutions. |
| 2032 | 7.46 | Expanding investment in healthcare M&A activities boosts development of transjugular intrahepatic portosystemic shunts. |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary research methodology, combining internal industry data, secondary research, and primary validation, updated periodically to reflect current market conditions. As markets evolve rapidly, figures for certain industries may vary slightly and are intended as informed estimates rather than absolute figures. For the most current market sizing, we recommend validating figures with a 6Wresearch analyst.
Below are some of the specific key takeaways from the market, including:
The Global Transjugular Intrahepatic Portosystemic Shunt (TIPS) market faces distinct challenges, particularly in terms of cost and awareness. TIPS procedures can range from USD 20,000 to USD 30,000, deterring some patients from seeking treatment. For example, in regions with limited health insurance coverage, the burden of these costs remains a substantial barrier to access.
The landscape of the Global Transjugular Intrahepatic Portosystemic Shunt (TIPS) market is evolving through various technological advancements and patient care strategies. One notable trend is the enhancement of imaging-guided approaches that improve the precision of TIPS placement. For instance, companies like Medtronic have invested significantly in developing advanced imaging techniques that facilitate easier identification of anatomical landmarks during procedures.
Moreover, integration of artificial intelligence in surgical planning is emerging as a transformative factor. By utilizing algorithms that analyze patient data, facilities can expedite procedural effectiveness while reducing the length of hospital stays, shaping future demand for TIPS procedures. The potential for these innovations highlights an operational shift toward data-driven methodologies.
The market presents various revenue opportunities, particularly through strategic collaborations and product development. For example, a joint venture between Terumo Corporation and a leading hospital in Europe has resulted in new device prototypes aimed at enhancing patient outcomes for TIPS procedures, expected to unveil by 2027.
Additionally, as awareness around liver health is rising, educational programs focusing on TIPS benefits are being established. This engagement is projected to expand market penetration throughout emerging economies, creating avenues for leading companies to broaden their geographical reach.
Among the various types in the Global Transjugular Intrahepatic Portosystemic Shunt market, Covered Stents dominate the landscape, capturing approximately 68% share in 2025. The preference for Covered Stents is largely attributable to their enhanced safety profile, which minimizes the risk of thrombosis.
Bare Metal Stents, while currently second, are projected to experience a rapid increase, with a CAGR of 12.0% from 2026 to 2032. This growth aligns with broader trends favoring outpatient treatments, as Bare Metal Stents often entail a shorter hospitalization period.
In terms of technology, Imaging-Guided Placement leads the Global Transjugular Intrahepatic Portosystemic Shunt market with a share of ~70% in 2025. This approach leverages real-time imaging to ensure optimal placement of TIPS devices, reducing procedural errors substantially.
AI-Based Surgical Planning, while currently representing a smaller segment, is expected to grow at a CAGR of 15.0% from 2026 to 2032. This remarkable growth can be attributed to its potential to enhance procedural accuracy and effectiveness, addressing critical patient safety considerations.
Within the Global Transjugular Intrahepatic Portosystemic Shunt (TIPS) market, Liver Cirrhosis stands out as the largest application segment, commanding a share of ~60% in 2025. The prevalence of cirrhosis, often resulting from alcohol abuse or hepatitis, necessitates immediate intervention, thus driving this segment's dominance.
Portal Hypertension, while currently ranked second, is projected to be the fastest-growing application area, with a CAGR of 13.5% from 2026 to 2032. As understanding of the serious complications arising from portal hypertension increases, the demand for effective management using TIPS is expected to rise accordingly.
In the Global Transjugular Intrahepatic Portosystemic Shunt market, Hospitals constitute the largest end-user segment, capturing an estimated share of ~75% in 2025. This dominance is largely due to the concentration of resources and specialized staff needed to perform TIPS procedures within hospital settings.
Specialty Clinics are expected to grow at a CAGR of 11.0% from 2026 to 2032, reflecting an increasing trend towards decanting advanced procedures outside traditional hospital environments. This shift presents significant growth potential as healthcare continues to evolve toward more accessible treatment options.
North America emerges as the largest region in the Global Transjugular Intrahepatic Portosystemic Shunt market, holding approximately 45% share in 2025. The region benefits from advanced healthcare infrastructure, high awareness levels, and substantial investments in liver disease management.
Conversely, Asia is anticipated to be the fastest-growing region, with a CAGR of 12.0% from 2026 to 2032. With rising healthcare expenditures, increasing population awareness about liver diseases, and the expansion of healthcare facilities, Asia is set to play a crucial role in reshaping market dynamics.
Government initiatives are key drivers in the Global Transjugular Intrahepatic Portosystemic Shunt market, influencing regulatory frameworks and healthcare accessibility. These actions can enhance funding, improve healthcare infrastructure, and stimulate innovation in treatment methods, thereby shaping competitive dynamics.
The Global Transjugular Intrahepatic Portosystemic Shunt Market is anticipated to undergo significant transformations driven by increasing investments in liver disease management and technological advancement. Notably, Boston Scientific is actively enhancing its product offerings, focusing on stent designs that better address patient safety. As TIPS becomes a standard practice in managing liver-related conditions, shifts in treatment protocols and accessibility will likely reshape the competitive landscape through 2032.
Recent developments in the Global Transjugular Intrahepatic Portosystemic Shunt market showcase firms enhancing their portfolios and strategies to maintain a competitive edge. Key highlights include:
The competitive structure of the Global Transjugular Intrahepatic Portosystemic Shunt market is moderately consolidated, with a few companies leading due to their advanced technologies and established market presence. However, the entry of innovative startups and ongoing collaborations fosters a dynamic environment that fuels competition.
| Leading Company | Core Strength | Strategic Focus |
|---|---|---|
| Boston Scientific | Innovative stent designs | Expand product line and global reach |
| Terumo Corporation | R&D investment in advanced devices | Enhance procedural effectiveness |
| Cook Medical | Strong market presence and diverse offerings | Strategic acquisitions and partnerships |
| Medtronic | Technological advancement in TIPS | Emphasize AI integration in procedures |
| Weigao Group | Cost-effective product solutions | Focus on regional market penetration |
As competition intensifies, companies will likely pursue collaborations and technology enhancements, setting the stage for innovation and improved patient outcomes in TIPS procedures.
Global Transjugular Intrahepatic Portosystemic Shunt Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Transjugular Intrahepatic Portosystemic Shunt Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Transjugular Intrahepatic Portosystemic Shunt Market Revenues & Volume, 2022 & 2032F |
3.3 Global Transjugular Intrahepatic Portosystemic Shunt Market - Industry Life Cycle |
3.4 Global Transjugular Intrahepatic Portosystemic Shunt Market - Porter's Five Forces |
3.5 Global Transjugular Intrahepatic Portosystemic Shunt Market Revenues & Volume Share, By Regions, 2022 & 2032F |
3.6 Global Transjugular Intrahepatic Portosystemic Shunt Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.7 Global Transjugular Intrahepatic Portosystemic Shunt Market Revenues & Volume Share, By Technology, 2022 & 2032F |
3.8 Global Transjugular Intrahepatic Portosystemic Shunt Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.9 Global Transjugular Intrahepatic Portosystemic Shunt Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Global Transjugular Intrahepatic Portosystemic Shunt Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Transjugular Intrahepatic Portosystemic Shunt Market Trends |
6 Global Transjugular Intrahepatic Portosystemic Shunt Market, 2022-2032 |
6.1 Global Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Type, 2022-2032 |
6.1.1 Overview & Analysis |
6.1.2 Global Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Covered Stents, 2022-2032 |
6.1.3 Global Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Bare Metal Stents, 2022-2032 |
6.1.4 Global Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Others, 2022-2032 |
6.2 Global Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Technology, 2022-2032 |
6.2.1 Overview & Analysis |
6.2.2 Global Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Imaging-Guided Placement, 2022-2032 |
6.2.3 Global Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By AI-Based Surgical Planning, 2022-2032 |
6.3 Global Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Application, 2022-2032 |
6.3.1 Overview & Analysis |
6.3.2 Global Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Liver Cirrhosis, 2022-2032 |
6.3.3 Global Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Portal Hypertension, 2022-2032 |
6.3.4 Global Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Variceal Bleeding, 2022-2032 |
6.4 Global Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By End User, 2022-2032 |
6.4.1 Overview & Analysis |
6.4.2 Global Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Hospitals, 2022-2032 |
6.4.3 Global Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Specialty Clinics, 2022-2032 |
6.4.4 Global Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Research Institutes, 2022-2032 |
7 North America Transjugular Intrahepatic Portosystemic Shunt Market, Overview & Analysis |
7.1 North America Transjugular Intrahepatic Portosystemic Shunt Market Revenues & Volume, 2022-2032 |
7.2 North America Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Countries, 2022-2032 |
7.2.1 United States (US) Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
7.2.2 Canada Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
7.2.3 Rest of North America Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
7.3 North America Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Type, 2022-2032 |
7.4 North America Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Technology, 2022-2032 |
7.5 North America Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Application, 2022-2032 |
7.6 North America Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By End User, 2022-2032 |
8 Latin America (LATAM) Transjugular Intrahepatic Portosystemic Shunt Market, Overview & Analysis |
8.1 Latin America (LATAM) Transjugular Intrahepatic Portosystemic Shunt Market Revenues & Volume, 2022-2032 |
8.2 Latin America (LATAM) Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Countries, 2022-2032 |
8.2.1 Brazil Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
8.2.2 Mexico Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
8.2.3 Argentina Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
8.2.4 Rest of LATAM Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
8.3 Latin America (LATAM) Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Type, 2022-2032 |
8.4 Latin America (LATAM) Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Technology, 2022-2032 |
8.5 Latin America (LATAM) Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Application, 2022-2032 |
8.6 Latin America (LATAM) Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By End User, 2022-2032 |
9 Asia Transjugular Intrahepatic Portosystemic Shunt Market, Overview & Analysis |
9.1 Asia Transjugular Intrahepatic Portosystemic Shunt Market Revenues & Volume, 2022-2032 |
9.2 Asia Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Countries, 2022-2032 |
9.2.1 India Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
9.2.2 China Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
9.2.3 Japan Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
9.2.4 Rest of Asia Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
9.3 Asia Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Type, 2022-2032 |
9.4 Asia Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Technology, 2022-2032 |
9.5 Asia Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Application, 2022-2032 |
9.6 Asia Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By End User, 2022-2032 |
10 Africa Transjugular Intrahepatic Portosystemic Shunt Market, Overview & Analysis |
10.1 Africa Transjugular Intrahepatic Portosystemic Shunt Market Revenues & Volume, 2022-2032 |
10.2 Africa Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Countries, 2022-2032 |
10.2.1 South Africa Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
10.2.2 Egypt Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
10.2.3 Nigeria Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
10.2.4 Rest of Africa Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
10.3 Africa Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Type, 2022-2032 |
10.4 Africa Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Technology, 2022-2032 |
10.5 Africa Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Application, 2022-2032 |
10.6 Africa Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By End User, 2022-2032 |
11 Europe Transjugular Intrahepatic Portosystemic Shunt Market, Overview & Analysis |
11.1 Europe Transjugular Intrahepatic Portosystemic Shunt Market Revenues & Volume, 2022-2032 |
11.2 Europe Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Countries, 2022-2032 |
11.2.1 United Kingdom Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
11.2.2 Germany Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
11.2.3 France Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
11.2.4 Rest of Europe Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
11.3 Europe Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Type, 2022-2032 |
11.4 Europe Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Technology, 2022-2032 |
11.5 Europe Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Application, 2022-2032 |
11.6 Europe Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By End User, 2022-2032 |
12 Middle East Transjugular Intrahepatic Portosystemic Shunt Market, Overview & Analysis |
12.1 Middle East Transjugular Intrahepatic Portosystemic Shunt Market Revenues & Volume, 2022-2032 |
12.2 Middle East Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Countries, 2022-2032 |
12.2.1 Saudi Arabia Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
12.2.2 UAE Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
12.2.3 Turkey Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, 2022-2032 |
12.3 Middle East Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Type, 2022-2032 |
12.4 Middle East Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Technology, 2022-2032 |
12.5 Middle East Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By Application, 2022-2032 |
12.6 Middle East Transjugular Intrahepatic Portosystemic Shunt Market, Revenues & Volume, By End User, 2022-2032 |
13 Global Transjugular Intrahepatic Portosystemic Shunt Market Key Performance Indicators |
14 Global Transjugular Intrahepatic Portosystemic Shunt Market - Export/Import By Countries Assessment |
15 Global Transjugular Intrahepatic Portosystemic Shunt Market - Opportunity Assessment |
15.1 Global Transjugular Intrahepatic Portosystemic Shunt Market Opportunity Assessment, By Countries, 2022 & 2032F |
15.2 Global Transjugular Intrahepatic Portosystemic Shunt Market Opportunity Assessment, By Type, 2022 & 2032F |
15.3 Global Transjugular Intrahepatic Portosystemic Shunt Market Opportunity Assessment, By Technology, 2022 & 2032F |
15.4 Global Transjugular Intrahepatic Portosystemic Shunt Market Opportunity Assessment, By Application, 2022 & 2032F |
15.5 Global Transjugular Intrahepatic Portosystemic Shunt Market Opportunity Assessment, By End User, 2022 & 2032F |
16 Global Transjugular Intrahepatic Portosystemic Shunt Market - Competitive Landscape |
16.1 Global Transjugular Intrahepatic Portosystemic Shunt Market Revenue Share, By Companies, 2025 |
16.2 Global Transjugular Intrahepatic Portosystemic Shunt Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here